TargeGen announces relocation
US-based biopharmaceutical company TargeGen is to relocate its San Diego-based operations to a larger facility in San Diego in mid-January 2006.
US-based biopharmaceutical company TargeGen is to relocate its San Diego-based operations to a larger facility in San Diego in mid-January 2006.
The move to 9380 Judicial Drive, San Diego, California 92121, effective 16 January 2006, will see the company increase its laboratory and office space from 18,500ft2 to approximately 43,000ft2.
A privately held vascular biology-focused company, TargeGen is developing novel small molecule kinase inhibitors, through the targeting of certain biochemical processes associated with vascular proliferation and vascular permeability, for the treatment of heart attacks, eye disease and cancer.